CYPH

Cypherpunk Technologies Inc.
NASDAQFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$74.55M
P/E Ratio
EPS
$-0.02
Beta
0.06
52W High
$3.70
52W Low
$0.23
50-Day MA
$0.91
200-Day MA
$0.90
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA$-36.69M
Operating Margin0.00%
Return on Equity-108.20%
Return on Assets-26.20%
Revenue/Share (TTM)$0.00
Book Value$0.90
Price-to-Book0.84
Price-to-Sales (TTM)160.10
EV/Revenue-
EV/EBITDA11.21
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$106.46M
Float$89.12M
% Insiders8.44%
% Institutions14.66%

Historical Volatility

HV 10-Day
HV 20-Day
HV 30-Day
HV 60-Day
HV Rank

Latest News

More FINANCIAL SERVICES Stocks

Data last updated: 7/9/2026